Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 5,5-diphenylhydantoin
2. 5,5-diphenylimidazolidine-2,4-dione
3. Antisacer
4. Difenin
5. Dihydan
6. Dilantin
7. Diphenylhydantoin
8. Diphenylhydantoinate, Sodium
9. Epamin
10. Epanutin
11. Fenitoin
12. Hydantol
13. Phenhydan
14. Phenytoin
15. Sodium Diphenylhydantoinate
1. 630-93-3
2. 5,5-diphenylhydantoin Sodium Salt
3. Dilantin Sodium
4. Diphenylhydantoin Sodium
5. Diphantoine
6. Tacosal
7. Antisacer
8. Phenytoin Sodium Salt
9. Diphentoin
10. Epanutin
11. Solantoin
12. Solantyl
13. Eptoin
14. Sodium Phenytoin
15. Diphenylan Sodium
16. Sodium 2,5-dioxo-4,4-diphenylimidazolidin-1-ide
17. Phenytek
18. Sodium Diphenylhydantoin
19. 5,5-diphenylhydantoin Sodium
20. Mls000554076
21. 2,4-imidazolidinedione, 5,5-diphenyl-, Monosodium Salt
22. 4182431bjh
23. Citrullamon
24. Fenidantoin
25. Novodiphenyl
26. Aladdin
27. Alepsin
28. Cumatil
29. Decatona
30. Dihydan
31. Ditomed
32. Enkefal
33. Epdantoin
34. Epileptin
35. Epsolin
36. Eptolin
37. Fenigramon
38. Fenitron
39. Fenytoin
40. Hidantin
41. Phenilep
42. Smr000146393
43. Ditoin
44. Episar
45. Muldis
46. Fenitoin Sodium
47. Hidantal Sodium
48. Lepitoin Sodium
49. Denyl Sodium
50. Aleviatin Sodium
51. Diphenine Sodium
52. Epilantin-e
53. Fenitoina Sodica
54. Soluble Phenytoin
55. Dilantin Infatabs
56. Metinal Idantoina
57. Di-len
58. Dilantin Injection
59. Dilantin Suspension
60. Om-hydantoine Sodium
61. Sdph
62. Prompt Phenytoin Sodium
63. Sodium;5,5-diphenylimidazolidin-3-ide-2,4-dione
64. Mls000028562
65. Sodium Diphenyl Hydantoinate
66. Diphenylhydantoin Sodium Salt
67. Sodium 5,5-diphenylhydantoinate
68. Phenytoin, Sodium Salt
69. Sodium 5,5-diphenyl Hydantoinate
70. Nsc-757274
71. Extended Phenytoin Sodium
72. Smr000058987
73. Einecs 211-148-2
74. Mfcd00069674
75. Hydantoin, 5,5-diphenyl-, Sodium Salt
76. Phenytoin Sodium [usp:jan]
77. Sodium 5,5-diphenylhydantoin
78. Diphenylhydantoin, Sodium Salt
79. Sodium 5,5-diphenyl-2,4-imidazolidinedione
80. Unii-4182431bjh
81. Hydantoin, 5,5-diphenyl-, Monosodium Salt
82. Opera_id_1233
83. Dsstox_cid_3775
84. Dsstox_rid_77190
85. Dsstox_gsid_23775
86. Spectrum1500485
87. Schembl3051683
88. Dtxsid2023775
89. Phenytoin Sodium [vandf]
90. Hms501j09
91. 5,5-diphenylhydatoin Sodium Salt
92. Phenytoin Sodium [mart.]
93. Phenytoin Sodium [usp-rs]
94. Phenytoin Sodium [who-dd]
95. Phenytoin Sodium [who-ip]
96. Hms1920h10
97. Hms2091p14
98. Hms2233k24
99. Hms3259h11
100. Hms3373o11
101. Phenytoin Sodium Salt [mi]
102. Tox21_302338
103. Ccg-39219
104. Akos003273947
105. Akos015951389
106. Akos025310163
107. Phenytoin Sodium [ep Impurity]
108. Phenytoin Sodium [orange Book]
109. Nc00642
110. Nsc 757274
111. Phenytoin Sodium [ep Monograph]
112. 5,5-diphenylhydantoin Sodium Sigmaultra
113. Phenytoin Sodium [usp Monograph]
114. Ncgc00094758-01
115. Ncgc00094758-02
116. Ncgc00164434-01
117. Ncgc00255285-01
118. As-13308
119. Cas-630-93-3
120. 5,5-diphenylhydantoin Sodium Salt, >=99%
121. Phenytoinum Natricum [who-ip Latin]
122. D1331
123. Diphenylhydantoin Sodium [green Book]
124. Phenytoin Sodium For Injection [jan]
125. En300-49847
126. H12023
127. A834211
128. Sr-05000001698
129. Q-201564
130. Sr-05000001698-1
131. Q27258415
132. 2,4-imidazolidinedione, 5,5-diphenyl-, Sodium Salt (1:1)
133. Phenytoin Sodium, European Pharmacopoeia (ep) Reference Standard
134. Phenytoin Sodium, United States Pharmacopeia (usp) Reference Standard
135. Phenytoin Sodium, Pharmaceutical Secondary Standard; Certified Reference Material
1. Phenylhydantoin
Molecular Weight | 274.25 g/mol |
---|---|
Molecular Formula | C15H11N2NaO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 2 |
Exact Mass | 274.07182188 g/mol |
Monoisotopic Mass | 274.07182188 g/mol |
Topological Polar Surface Area | 47.2 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 356 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Phenytoin sodium |
Drug Label | Phenytoin sodium is an antiepileptic drug. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring. The chemical name is sodium 5,5-diphenyl-2, 4-imidazolidinedione, having the following structural formula:... |
Active Ingredient | Phenytoin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/ml |
Market Status | Prescription |
Company | Hospira; Hikma Maple; X-gen Pharms; Luitpold |
2 of 2 | |
---|---|
Drug Name | Phenytoin sodium |
Drug Label | Phenytoin sodium is an antiepileptic drug. Phenytoin sodium is related to the barbiturates in chemical structure, but has a five-membered ring. The chemical name is sodium 5,5-diphenyl-2, 4-imidazolidinedione, having the following structural formula:... |
Active Ingredient | Phenytoin sodium |
Dosage Form | Injectable |
Route | Injection |
Strength | 50mg/ml |
Market Status | Prescription |
Company | Hospira; Hikma Maple; X-gen Pharms; Luitpold |
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Cytochrome P-450 CYP1A2 Inducers
Drugs and compounds that induce the synthesis of CYTOCHROME P-450 CYP1A2. (See all compounds classified as Cytochrome P-450 CYP1A2 Inducers.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7348
Submission : 1988-02-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15848
Submission : 2002-01-31
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7304
Submission : 1988-01-22
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16301
Submission : 2002-12-05
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-10-14
Pay. Date : 2015-09-30
DMF Number : 17862
Submission : 2004-12-02
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-28
Pay. Date : 2015-09-15
DMF Number : 5384
Submission : 1984-06-06
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20433
Submission : 2007-03-25
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20453
Submission : 2007-04-17
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7229
Submission : 1987-11-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4531
Submission : 1982-04-07
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Application : Fillers, Diluents & Binders, Taste Masking
Excipient Details : Mannitol is used as a filler, bulking agent and taste masking agent in ODT formulations such as tablets.
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Capsule, Granule / Pellet, Tablet, Injectable / Parenteral
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Thickeners and Stabilizers
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders
Brand Name : Lactose Monohydrate
Application : Parenteral
Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.
Dosage Form : Injectable / Parenteral, Tablet
Grade : Parenteral, Oral
Category : Fillers, Diluents & Binders, Parenteral, Thickeners and Stabilizers
Global Sales Information
Market Place
Reply
17 Dec 2024
Reply
24 Oct 2024
Reply
20 Jun 2023
Reply
20 Oct 2022
Reply
10 Aug 2022
Reply
21 Oct 2021
Reply
20 Sep 2021
Reply
29 Jan 2019
Reply
16 Jan 2019
Reply
16 Mar 2020
Reply
16 Nov 2019
Reply
03 Mar 2016
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Phenytoin Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phenytoin Sodium, including repackagers and relabelers. The FDA regulates Phenytoin Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phenytoin Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Phenytoin Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Phenytoin Sodium supplier is an individual or a company that provides Phenytoin Sodium active pharmaceutical ingredient (API) or Phenytoin Sodium finished formulations upon request. The Phenytoin Sodium suppliers may include Phenytoin Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Phenytoin Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Phenytoin Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Phenytoin Sodium active pharmaceutical ingredient (API) in detail. Different forms of Phenytoin Sodium DMFs exist exist since differing nations have different regulations, such as Phenytoin Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Phenytoin Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Phenytoin Sodium USDMF includes data on Phenytoin Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Phenytoin Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Phenytoin Sodium suppliers with USDMF on PharmaCompass.
A Phenytoin Sodium CEP of the European Pharmacopoeia monograph is often referred to as a Phenytoin Sodium Certificate of Suitability (COS). The purpose of a Phenytoin Sodium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Phenytoin Sodium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Phenytoin Sodium to their clients by showing that a Phenytoin Sodium CEP has been issued for it. The manufacturer submits a Phenytoin Sodium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Phenytoin Sodium CEP holder for the record. Additionally, the data presented in the Phenytoin Sodium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Phenytoin Sodium DMF.
A Phenytoin Sodium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Phenytoin Sodium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Phenytoin Sodium suppliers with CEP (COS) on PharmaCompass.
A Phenytoin Sodium written confirmation (Phenytoin Sodium WC) is an official document issued by a regulatory agency to a Phenytoin Sodium manufacturer, verifying that the manufacturing facility of a Phenytoin Sodium active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Phenytoin Sodium APIs or Phenytoin Sodium finished pharmaceutical products to another nation, regulatory agencies frequently require a Phenytoin Sodium WC (written confirmation) as part of the regulatory process.
click here to find a list of Phenytoin Sodium suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Phenytoin Sodium as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Phenytoin Sodium API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Phenytoin Sodium as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Phenytoin Sodium and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Phenytoin Sodium NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Phenytoin Sodium suppliers with NDC on PharmaCompass.
Phenytoin Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Phenytoin Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Phenytoin Sodium GMP manufacturer or Phenytoin Sodium GMP API supplier for your needs.
A Phenytoin Sodium CoA (Certificate of Analysis) is a formal document that attests to Phenytoin Sodium's compliance with Phenytoin Sodium specifications and serves as a tool for batch-level quality control.
Phenytoin Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Phenytoin Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Phenytoin Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Phenytoin Sodium EP), Phenytoin Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Phenytoin Sodium USP).
LOOKING FOR A SUPPLIER?